IHC revealed that the levels of TUBB3 were higher in conventional papillary carcinomas (cPTCs) and anaplastic thyroid carcinomas (ATCs). This evidence concerns the gene TUBB3 and thyroid gland undifferentiated (anaplastic) carcinoma.